Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction
- PMID: 29615110
- PMCID: PMC5883284
- DOI: 10.1186/s40168-018-0441-4
Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction
Abstract
Background: Post-infarction cardiovascular remodeling and heart failure are the leading cause of myocardial infarction (MI)-driven death during the past decades. Experimental observations have involved intestinal microbiota in the susceptibility to MI in mice; however, in humans, identifying whether translocation of gut bacteria to systemic circulation contributes to cardiovascular events post-MI remains a major challenge.
Results: Here, we carried out a metagenomic analysis to characterize the systemic bacteria in a cohort of 49 healthy control individuals, 50 stable coronary heart disease (CHD) subjects, and 100 ST-segment elevation myocardial infarction (STEMI) patients. We report for the first time higher microbial richness and diversity in the systemic microbiome of STEMI patients. More than 12% of post-STEMI blood bacteria were dominated by intestinal microbiota (Lactobacillus, Bacteroides, and Streptococcus). The significantly increased product of gut bacterial translocation (LPS and D-lactate) was correlated with systemic inflammation and predicted adverse cardiovascular events. Following experimental MI, compromised left ventricle (LV) function and intestinal hypoperfusion drove gut permeability elevation through tight junction protein suppression and intestinal mucosal injury. Upon abrogation of gut bacterial translocation by antibiotic treatment, both systemic inflammation and cardiomyocyte injury in MI mice were alleviated.
Conclusions: Our results provide the first evidence that cardiovascular outcomes post-MI are driven by intestinal microbiota translocation into systemic circulation. New therapeutic strategies targeting to protect the gut barrier and eliminate gut bacteria translocation may reduce or even prevent cardiovascular events post-MI.
Keywords: Cardiovascular outcome; Gut permeability; Microbial translocation; Myocardial infarction.
Conflict of interest statement
Authors’ information
Correspondence and requests for materials should be addressed to Jun Cai (caijun@fuwaihospital.org) and Yuming Li (cardiolab@gmail.com).
Ethics approval and consent to participate
The study was approved by local ethics committees (Pingjin Hospital Heart Center and Beijing Fuwai Hospital), and informed consent was obtained from all subjects. All animal care and experiments were performed in accordance with the guidelines of Institutional Animal Care and Use Committee of Pingjin Hospital Heart Center.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5883284/bin/40168_2018_441_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5883284/bin/40168_2018_441_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5883284/bin/40168_2018_441_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5883284/bin/40168_2018_441_Fig4_HTML.gif)
![Fig. 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5883284/bin/40168_2018_441_Fig5_HTML.gif)
![Fig. 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5883284/bin/40168_2018_441_Fig6_HTML.gif)
![Fig. 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5883284/bin/40168_2018_441_Fig7_HTML.gif)
![Fig. 8](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5883284/bin/40168_2018_441_Fig8_HTML.gif)
Similar articles
-
Heart-gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion.Cardiovasc Res. 2023 Jun 13;119(6):1390-1402. doi: 10.1093/cvr/cvad023. Cardiovasc Res. 2023. PMID: 36715640 Free PMC article.
-
Prolonged Fever After ST-Segment Elevation Myocardial Infarction and Long-Term Cardiac Outcomes.J Am Heart Assoc. 2017 Jul 22;6(7):e005463. doi: 10.1161/JAHA.116.005463. J Am Heart Assoc. 2017. PMID: 28735289 Free PMC article.
-
Intramyocardial dissecting hematoma in anterior wall ST elevation myocardial infarction: impact on left ventricular remodeling and prognosis.Int J Cardiovasc Imaging. 2018 Feb;34(2):201-210. doi: 10.1007/s10554-017-1221-0. Epub 2017 Aug 1. Int J Cardiovasc Imaging. 2018. PMID: 28766162
-
Myocardial infarction and gut microbiota: An incidental connection.Pharmacol Res. 2018 Mar;129:308-317. doi: 10.1016/j.phrs.2017.11.008. Epub 2017 Nov 10. Pharmacol Res. 2018. PMID: 29133215 Review.
-
Gut as a target for cadmium toxicity.Environ Pollut. 2018 Apr;235:429-434. doi: 10.1016/j.envpol.2017.12.114. Epub 2018 Jan 5. Environ Pollut. 2018. PMID: 29310086 Review.
Cited by
-
Applied physiology: gut microbiota and antimicrobial therapy.Eur J Appl Physiol. 2024 Jun;124(6):1631-1643. doi: 10.1007/s00421-024-05496-1. Epub 2024 Apr 29. Eur J Appl Physiol. 2024. PMID: 38683402 Review.
-
Intrinsic and Extrinsic Contributors to the Cardiac Benefits of Exercise.JACC Basic Transl Sci. 2023 Oct 18;9(4):535-552. doi: 10.1016/j.jacbts.2023.07.011. eCollection 2024 Apr. JACC Basic Transl Sci. 2023. PMID: 38680954 Free PMC article. Review.
-
Do high-protein diets have the potential to reduce gut barrier function in a sex-dependent manner?Eur J Nutr. 2024 Apr 25. doi: 10.1007/s00394-024-03407-w. Online ahead of print. Eur J Nutr. 2024. PMID: 38662018
-
The Correlation Between Heart Failure and Gut Microbiome Metabolites.Infect Microbes Dis. 2020 Nov 4;2(4):136-143. doi: 10.1097/IM9.0000000000000042. eCollection 2020 Dec. Infect Microbes Dis. 2020. PMID: 38630083 Free PMC article. Review.
-
Oral-gut microbial transmission promotes diabetic coronary heart disease.Cardiovasc Diabetol. 2024 Apr 5;23(1):123. doi: 10.1186/s12933-024-02217-y. Cardiovasc Diabetol. 2024. PMID: 38581039 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous